From Powerbase
(Redirected from Novartis International AG)
Jump to: navigation, search


Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz. It has operations in 140 countries with its head office located in Switzerland.[1]

PR, Lobbying and Business Intelligence firms

Novartis is listed as a client for Business Insights[7] and Int/ext Communications.[8]

In 2008, Novartis is listed as a client of Innovex[9] and as a past or current client for FischerAppelt Kommunikation[10] and The Gorlin Group[11]. They are also listed as a member of the International Federation of Pharmaceutical Manufacturers and Associations.[12]

In 2008, Novartis Vaccines and Diagnostics is listed as a client of the Podesta Group.[13]


Novartis provided generous support for the Expert Consensus Guideline Series: Treatment of Schizophrenia 1999 an initiative aiming at establishing uniform medication guidelines for schizophrenia[14]. It is reported that this was an initiative 'supported exclusively by 6 pharmaceutical companies: Eli Lilly and Company, Janssen Pharmaceutica Inc., Novartis Pharmaceuticals Corporation, Ortho-McNeil Pharmaceutical, Pfizer Inc. and Zeneca Pharmaceuticals' (now known as AstraZeneca). Michael Hogan and Laurie Flynn were also involved in this initiative.

In 2004, Novartis Pharma AG is reported to have entered into a license agreement with ChemSource Corporation (a subsidiary of IVAX Corporation) 'to utilize the patented multi-dose dry powder inhaler, Airmax, for Novartis's trademarked medicines Foradil and Miflonide in the European Union and certain other countries'[15].

Novartis has been a donor to the Science Media Centre from 2010-2013 according to the SMC.[16]

Patient Groups

In February 2008, Novartis UK report sponsorship of the following patient groups[17]

Sponsoring Labour

Norvartis Pharmaceuticals UK Ltd is reported to have sponsored the Labour Party in excess of £5,000 in 1997[18].

Lobbying firms


  1. Novartis About Novartis Accessed 25th February 2008
  2. Incisive Health Clients, accessed 25 June 2015.
  3. Register 1st September 2014 - 30th November 2014 APPC, accessed 28 January 2015
  4. Register 1st December 2014 - 28th February 2015 APPC, accessed 30 March 2015
  5. Register 1st June 2014 - 31st August 2014 APPC, accessed 28 January 2015
  6. Register for 1st March 2013 - 31st May 2013 APPC, accessed 8 April 2015
  7. Business Insights Patient Power: The shift towards more informed, more powerful consumers of drugs Accessed 5th February 2008
  8. Public Relations Organisation International Int/ext Communications Accessed 13th February 2008
  9. Innovex Our Customers Accessed 12th February 2008
  10. FischerAppelt Kommunikation Current & former clients Accessed 14th February 2008
  11. The Gorlin Group Clients Accessed 20th March 2008
  12. International Federation of Pharmaceutical Manufacturers and Associations Members Accessed 11th March 2008
  13. Podesta Group Clients Accessed 21st March 2008
  14. Weibert, S. The Genesis of President Bush’s New Freedom Commission on Mental Health Teenscreen Truth. Accessed 9th January 2008
  15. Plunkett's Health Care Industry Almanac. 'IVAX Corporation.' January 2004
  16. Data from Internet Archive holdings of the Science Media Centre website, 2002-2013.
  17. Novartis UK UK Sponsorship Accessed 25th February 2008
  18. The Guardian 'Blair cuts union links with individual help: Labour's list of donors'. 31st August 1998
  19. Register 1st September 2014 - 30th November 2014 APPC, accessed 29 January 2015
  20. Register 1st September 2014 - 30th November 2014 APPC, accessed 29 January 2015
  21. Blue Rubicon profile, 2016, Registrar of consultant lobbyists, accessed 29 April 2016